Profile
| Metric | Value |
|---|---|
| Full Name | FibroGen, Inc. |
| Ticker | NASDAQ: FGEN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | fibrogen.com |
| Employees | 225 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $9.14 | |
| Price, 1D Change | +0.77% | |
| $37M | ||
| - | ||
| 0.23 | ||
| 1.21 | ||
| $30M | ||
| Revenue, 1Y Change | -36.71% | |
| -$11.89 | ||
| EPS, 1Y Change | +83.72% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:25 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$11.89 | ||
| EPS Estimate | -$6.97 | |
| EPS Est. Change | +41.38% | |
| $29.62M | ||
| Revenue Estimate | $6.75M | |
| Revenue Est. Change | -77.21% | |
| Current Price | $9.14 | |
| Price Target | - | $43.00 |
| Price Tgt. Change | - | +370.46% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.63 | -$73.03 | -2,676.71% | |
| -$0.86 | -$11.89 | -1,282.50% | |
| -$6.97 | N/A | +41.38% | |
| -$11.95 | N/A | -0.51% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $164.01M | $46.80M | -71.46% | |
| $177.85M | $29.62M | -83.34% | |
| $6.75M | N/A | -77.21% | |
| $6.10M | N/A | -79.41% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $9.14 | |
| $8.86 | ||
| SMA 200 vs Price | -3.03% | |
| $8.99 | ||
| SMA 50 vs Price | -1.60% | |
| 1.21 | ||
| $0.49 | ||
| 51.05 | ||
| 57.92% | ||
| 95.55% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $29.62M | ||
| -$11.89 | ||
| $14.06M | ||
| 47.47% | ||
| -$130.96M | ||
| -442.13% | ||
| -$153.10M | ||
| -160.63% | ||
| -$142.43M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -0.32 | ||
| 1.47 | ||
| 1.45 | ||
| -17.60 | ||
| 4 | ||
| -14.02 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 0.23 | ||
| 4.45 | ||
| -2.17 | ||
| 1.62 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$225.60M | ||
| $50.48M | ||
| $214.53M | ||
| $196.51M | ||
| $398.16M | ||
| $133.31M | ||
| $90.21M | ||
| $34.00K | ||
| $5.06M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $160.58M | ||
| $145.02M | ||
| $15.56M | ||
| $49.33M | ||
| $2.69M | ||
| $8.25M | ||
| -$269.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$138.00M | ||
| $125.99M | ||
| -$255.00K | ||
| $266.00K | ||
| -$138.27M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| B of A Securities | → | |
| Raymond James | → | |
| Goldman Sachs | → | |
| William Blair | → | |
| Stifel | → |
Analyst sentiment
Institutional ownership
Screeners with FGEN
FAQ
What is the ticker symbol for FibroGen, Inc.?
The ticker symbol for FibroGen, Inc. is NASDAQ:FGEN
Does FibroGen, Inc. pay dividends?
No, FibroGen, Inc. does not pay dividends
What sector is FibroGen, Inc. in?
FibroGen, Inc. is in the Healthcare sector
What industry is FibroGen, Inc. in?
FibroGen, Inc. is in the Biotechnology industry
What country is FibroGen, Inc. based in?
FibroGen, Inc. is headquartered in United States
When did FibroGen, Inc. go public?
FibroGen, Inc. initial public offering (IPO) was on November 14, 2014
Is FibroGen, Inc. in the S&P 500?
No, FibroGen, Inc. is not included in the S&P 500 index
Is FibroGen, Inc. in the NASDAQ 100?
No, FibroGen, Inc. is not included in the NASDAQ 100 index
Is FibroGen, Inc. in the Dow Jones?
No, FibroGen, Inc. is not included in the Dow Jones index
When was FibroGen, Inc. last earnings report?
FibroGen, Inc.'s most recent earnings report was on November 10, 2025
When does FibroGen, Inc. report earnings?
The next expected earnings date for FibroGen, Inc. is March 16, 2026
Data Sources & References
- FGEN Official Website www.fibrogen.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/921299/000119312525274241/0001193125-25-274241-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/921299/000095017025040280/0000950170-25-040280-index.htm
- FGEN Profile on Yahoo Finance finance.yahoo.com/quote/FGEN
- FGEN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/fgen